Global Live-type Poultry Vaccine Market Growth 2025-2031

The global Live-type Poultry Vaccine market size is predicted to grow from US$ 982 million in 2025 to US$ 1276 million in 2031; it is expected to grow at a CAGR of 4.5% from 2025 to 2031.

A live-type poultry vaccine contains a virus or bacteria that must infect the chicken and multiply in its body to produce immunity, preferably with minimal reaction. Multiplication of the virus in the chicken is necessary, as only relatively small amounts of virus are administered to the bird.

Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from £2.6bn in 2015 to £4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about ¥67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 590%.

LP Information, Inc. (LPI) ' newest research report, the “Live-type Poultry Vaccine Industry Forecast” looks at past sales and reviews total world Live-type Poultry Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Live-type Poultry Vaccine sales for 2025 through 2031. With Live-type Poultry Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live-type Poultry Vaccine industry.

This Insight Report provides a comprehensive analysis of the global Live-type Poultry Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live-type Poultry Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Live-type Poultry Vaccine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live-type Poultry Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live-type Poultry Vaccine.

This report presents a comprehensive overview, market shares, and growth opportunities of Live-type Poultry Vaccine market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
Newcastle Disease Vaccine
Infectious Bronchitis Vaccine
Fowl Pox Vaccine
Marek’s Disease Vaccine
Fowl Typhoid Vaccine
Live Coccidiosis Vaccine
Other

Segmentation by Application:
Chicken
Other Poultry

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
MERCK
Boehringer Ingelheim
ELANCO
QYH BIOTECH
CEVA
ZOETIS
Vaxxinova
PULIKE
PHIBRO ANIMAL HEALTH CORPORATION
JINYU BIOTECHNOLOGY
HARBIN PHARMACEUTICAL GROUP
MEVAC

Key Questions Addressed in this Report

What is the 10-year outlook for the global Live-type Poultry Vaccine market?

What factors are driving Live-type Poultry Vaccine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Live-type Poultry Vaccine market opportunities vary by end market size?

How does Live-type Poultry Vaccine break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.